HK1064616A1 - Remedies for vesical stimulation in association with prostatauxe - Google Patents

Remedies for vesical stimulation in association with prostatauxe

Info

Publication number
HK1064616A1
HK1064616A1 HK04107683A HK04107683A HK1064616A1 HK 1064616 A1 HK1064616 A1 HK 1064616A1 HK 04107683 A HK04107683 A HK 04107683A HK 04107683 A HK04107683 A HK 04107683A HK 1064616 A1 HK1064616 A1 HK 1064616A1
Authority
HK
Hong Kong
Prior art keywords
prostatauxe
vesical
remedies
stimulation
association
Prior art date
Application number
HK04107683A
Other languages
English (en)
Inventor
Tsuyoshi Yamagata
Kaoru Atsuki
Tetsuji Ohno
Shiro Shirakura
Akira Karasawa
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of HK1064616A1 publication Critical patent/HK1064616A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK04107683A 2001-03-30 2004-10-07 Remedies for vesical stimulation in association with prostatauxe HK1064616A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001099799 2001-03-30
PCT/JP2002/003169 WO2002078712A1 (fr) 2001-03-30 2002-03-29 Remedes de stimulation vesicale en association avec une hypertrophie de la prostate

Publications (1)

Publication Number Publication Date
HK1064616A1 true HK1064616A1 (en) 2005-02-04

Family

ID=18953302

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04107683A HK1064616A1 (en) 2001-03-30 2004-10-07 Remedies for vesical stimulation in association with prostatauxe

Country Status (13)

Country Link
US (1) US7354949B2 (ko)
EP (1) EP1380299A4 (ko)
JP (1) JP4104986B2 (ko)
KR (1) KR20040007477A (ko)
CN (1) CN1230178C (ko)
BR (1) BR0208416A (ko)
CA (1) CA2442472A1 (ko)
EA (1) EA006448B1 (ko)
HK (1) HK1064616A1 (ko)
HU (1) HUP0303610A3 (ko)
MX (1) MXPA03008815A (ko)
NO (1) NO20034357L (ko)
WO (1) WO2002078712A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2520680A1 (en) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. Antitussives
TW200501938A (en) * 2003-06-27 2005-01-16 Kyowa Hakko Kogyo Kk A medicament for therapeutic treating overactive urinary bladder accompany with cerebrovascular disorder
US20060160887A1 (en) * 2003-07-16 2006-07-20 Kyowa Hakko Kogyo Co., Ltd. Medicinal composition
CA2532806A1 (en) * 2003-07-16 2005-01-27 Kyowa Hakko Kogyo Co., Ltd. Medicinal composition
TW200522943A (en) * 2003-12-11 2005-07-16 Kyowa Hakko Kogyo Kk Fine crystallites and a pharmaceutical composition comprising them
TW200827367A (en) 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3847786B2 (ja) * 1995-10-16 2006-11-22 協和醗酵工業株式会社 三環性化合物
EA002322B1 (ru) 1997-04-15 2002-04-25 Киова Хакко Когио Ко., Лтд. Трициклические соединения

Also Published As

Publication number Publication date
BR0208416A (pt) 2004-03-02
WO2002078712A1 (fr) 2002-10-10
EP1380299A1 (en) 2004-01-14
NO20034357L (no) 2003-11-24
US7354949B2 (en) 2008-04-08
EA200301078A1 (ru) 2004-02-26
US20040110784A1 (en) 2004-06-10
JPWO2002078712A1 (ja) 2004-07-22
NO20034357D0 (no) 2003-09-29
CN1230178C (zh) 2005-12-07
EA006448B1 (ru) 2005-12-29
KR20040007477A (ko) 2004-01-24
JP4104986B2 (ja) 2008-06-18
CN1499974A (zh) 2004-05-26
HUP0303610A3 (en) 2005-02-28
CA2442472A1 (en) 2002-10-10
HUP0303610A2 (hu) 2004-03-01
MXPA03008815A (es) 2004-02-17
EP1380299A4 (en) 2009-05-06

Similar Documents

Publication Publication Date Title
IL174994A0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
EP1425066A4 (en) Defibrillators
GB0206033D0 (en) Compounds useful in therapy
GB2406928B (en) Facilitating and authenticating transactions
EP1463438A4 (en) ENDOMURAL THERAPY
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
GB0126879D0 (en) Combination therapy
GB0218526D0 (en) Combination therapy
EP1427478A4 (en) DEFIBRILLATORS
HK1064616A1 (en) Remedies for vesical stimulation in association with prostatauxe
GB0108485D0 (en) Combination therapy
GB0101933D0 (en) Therapy
GB0122746D0 (en) Defibrillator
SG110107A1 (en) Compound and use in treatment
HUP0202120A3 (en) Anti tumorous combination
HUP0303609A3 (en) Remedies for vesical hyperesthesia
GB0329693D0 (en) Compounds useful in therapy
IL147696A0 (en) Combination therapy
AU2002244945A1 (en) Remedies for visical stimulation in association with prostatauxe
GB0312340D0 (en) Improved game and aricle for use with the game
EP1386919A4 (en) REMEDIES
GB0014046D0 (en) Compounds useful in therapy
GB0303289D0 (en) Combination therapy
AU2425P (en) CONCA D'OR Lilium hybrid
GB0325598D0 (en) Compound and use in treatment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100329